Dopamine oxidation Merchandise as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson’s Sickness.
The preferential degeneration of dopaminergic neurons inside the substantia nigra pars compacta is accountable for the motor impairment associated to Parkinson’s sickness. Dopamine is a extraordinarily reactive molecule, which is often saved inside synaptic vesicles the place it is stabilized by the ambient low pH.
Nonetheless, free cytosolic dopamine can auto-oxidize, producing reactive oxygen species, and end result within the formation of toxic quinones. Throughout the present work, we’ve got now analyzed the mechanisms by the use of which the dysfunction of dopamine homeostasis might induce cell toxicity, by focusing particularly on the hurt induced by dopamine oxidation merchandise on the mitochondrial diploma.
Our outcomes level out that dopamine derivatives impact mitochondrial morphology and induce mitochondrial membrane depolarization, leading to a reduction of ATP synthesis. Moreover, our outcomes counsel that opening of the mitochondrial transition pore induced by dopamine-derived quinones may contribute to the exact Parkinson’s disease-associated vulnerability of dopamine containing neurons.
NATtrol Epstein Barr Virus (EBV) Strain:B95-8,External Run Control-Medium(6X1mL) |
|||
| NATEBV-ERCM | Zeptometrix | 6X1mL | EUR 391.12 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 2 (EBNA2) |
|||
| 1-CSB-YP718162EEZ(A4) | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 2(EBNA2),partial expressed in Yeast |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3) |
|||
| 1-CSB-EP319032EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3),partial expressed in E.coli |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 1 (EBNA1) |
|||
| 1-CSB-EP365878EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 1(EBNA1),partial expressed in E.coli |
|||
Mouse antibody for Epstein-Barr virus gp 250/350 |
|||
| 221 | Virostat | 100 ug | EUR 321.88 |
|
Description: This is purified Mouse monoclonal antibody against Epstein-Barr virus gp 250/350 for WB, ELISA. |
|||
Mouse antibody for Epstein-Barr virus Bam H1 Z |
|||
| 256 | Virostat | 100 ug | EUR 321.88 |
|
Description: This is purified Mouse monoclonal antibody against Epstein-Barr virus Bam H1 Z for WB, ELISA. |
|||
NATtrol Epstein Barr Virus (EBV) Strain: B95-8, External Run Control-Low (6X1mL) |
|||
| NATEBV-ERCL | Zeptometrix | 6X1mL | EUR 329.76 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Anti-Epstein Barr Virus antibody |
|||
| STJ16100364 | St John's Laboratory | 1 mL | EUR 754 |
Epstein-Barr Virus Nuclear Antigen |
|||
| abx670096-01mg | Abbexa | 0.1 mg | EUR 1191 |
Epstein-Barr Virus (EBV) Antibody |
|||
| abx021696-1mg | Abbexa | 1 mg | EUR 1156 |
Epstein-Barr Virus (EBV) Antibody |
|||
| abx021699-1mg | Abbexa | 1 mg | EUR 1156 |
Epstein-Barr Virus (EBV) Antibody |
|||
| abx021702-1mg | Abbexa | 1 mg | EUR 1156 |
ELISA kit for Human epstein-barr virus (EBv)antibody (IgG) |
|||
| EK0203 | SAB | 96 tests | EUR 830 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human epstein-barr virus (EBv)antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Human epstein-barr virus (Ebv) antibody (IgM) |
|||
| EK0204 | SAB | 96 tests | EUR 830 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human epstein-barr virus (Ebv) antibody (IgM) in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Purified Nipah virus Glycoprotein control for Western Blotting |
|||
| NIV11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Purified Nipah virus Nucleoprotein control for Western Blotting |
|||
| NIV21-C | Alpha Diagnostics | 100 ul | EUR 225 |
Epstein-Barr virus Glycoprotein BDLF3 (BDLF3) |
|||
| 1-CSB-EP365881EFA1 | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Glycoprotein BDLF3(BDLF3),partial expressed in E.coli |
|||
Anti-Human Epstein-Barr Virus antibody |
|||
| STJ16100457 | St John's Laboratory | 1 mL | EUR 240 |
Anti-Epstein-Barr virus LMP antibody |
|||
| STJ16100853 | St John's Laboratory | 1 mL | EUR 964 |
Epstein-Barr Virus (EBV) Antibody (FITC) |
|||
| abx021698-100ug | Abbexa | 100 ug | EUR 732 |
ELISA kit for Mouse EBI3 (Epstein Barr Virus Induced Protein 3) |
|||
| ELK6316 | ELK Biotech | 1 plate of 96 wells | EUR 432 |
|
Description: A sandwich ELISA kit for detection of Epstein Barr Virus Induced Protein 3 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Control/Blocking peptide for Tobacco Mosaic Virus Movement Protein |
|||
| TMVMP11-P | Alpha Diagnostics | 100 ug | EUR 164 |
Zika Virus prM Protein (African) control for Western blot |
|||
| ZPRM11-C | Alpha Diagnostics | 100 ul | EUR 286 |
Mayaro virus (MAYV) Capsid Protein control for Western Blotting |
|||
| MAYV31-C | Alpha Diagnostics | 100 ul | EUR 286 |
Mayaro virus (MAYV) nsP1 protein control for Western Blotting |
|||
| MAYV41-C | Alpha Diagnostics | 100 ul | EUR 286 |
Mayaro virus (MAYV) 6K Protein control for Western Blotting |
|||
| MAYV51-C | Alpha Diagnostics | 100 ug | EUR 286 |
Mayaro virus (MAYV) E3 protein control for Western Blotting |
|||
| MAYV61-C | Alpha Diagnostics | 100 ul | EUR 286 |
Camelpox virus H3L/p35 protein control for western blot |
|||
| CPOX11-C | Alpha Diagnostics | 100 ul | EUR 286 |
pGreenPuro Scramble Hairpin Control - Virus (for shRNAs and miRZips) |
|||
| MZIP000-VA-1 | SBI | >1 x 10^6 IFUs | EUR 716 |
Goat IgG (-ve control for flow cytometry) (isotype control) |
|||
| 20011-100 | Alpha Diagnostics | 100 test | EUR 103 |
BSA Control for AGE-BSA |
|||
| 35R-AA007 | Fitzgerald | 10 mg | EUR 224 |
|
Description: BSA Control for AGE protein (BSA modified), Cat No. 30R-AA007 |
|||
BSA Control for Age-BSA |
|||
| 2221-BSA | Biovision | EUR 175 | |
Epstein-Barr virus Apoptosis regulator BHRF1 (BHRF1) |
|||
| 1-CSB-EP314488EFC | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Apoptosis regulator BHRF1(BHRF1),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein B (gB) |
|||
| 1-CSB-EP355975EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein B(gB),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein L (gL) |
|||
| 1-CSB-EP355982EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein L(gL) expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein GP350 (BLLF1) |
|||
| 1-CSB-EP360986EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein GP350(BLLF1),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein H (gH) |
|||
| 1-CSB-EP365883EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein H(gH),partial expressed in E.coli |
|||
Recombinant Epstein–Barr Virus P23, GST-tagged |
|||
| DAG511 | Creative Diagnostics | 1mg | EUR 1112 |
Epstein Barr Virus NA1 IgA ELISA Kit |
|||
| DEIA1030 | Creative Diagnostics | 96T | EUR 556 |
|
Description: For the qualitative determination of IgA class antibodies against Epstein Barr Virus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by Epstein Barr Virus. |
|||
Epstein Barr Virus Zta IgA ELISA Kit |
|||
| DEIA1034 | Creative Diagnostics | 96T | EUR 556 |
|
Description: For the qualitative determination of IgA class antibodies against Epstein Barr Virus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by Epstein Barr Virus. |
|||
Human Epstein-Barr Virus (EBV) ELISA Kit |
|||
| abx054176-96tests | Abbexa | 96 tests | EUR 668 |
Recombinant Epstein-Barr Virus (HHV-4) p18 |
|||
| 7-07795 | CHI Scientific | 100µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p18 |
|||
| 7-07796 | CHI Scientific | 500µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p18 |
|||
| 7-07797 | CHI Scientific | 1000µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p23 |
|||
| 7-07804 | CHI Scientific | 100µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p23 |
|||
| 7-07805 | CHI Scientific | 500µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p23 |
|||
| 7-07806 | CHI Scientific | 1000µg | Ask for price |
Epstein-Barr virus EBNA-1 recombinant antigen |
|||
| 8916 | Virostat | 100 ug | EUR 615.5 |
|
Description: This is Epstein-Barr virus EBNA-1 recombinant antigen for ELISA,WB. |
|||
Recombinant Human Epstein Barr Virus Induced 3 |
|||
| 7-00256 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Epstein Barr Virus Induced 3 |
|||
| 7-00257 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Epstein Barr Virus Induced 3 |
|||
| 7-00258 | CHI Scientific | 1mg | Ask for price |
Recombinant Mouse Epstein Barr Virus Induced 3 |
|||
| 7-00262 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Epstein Barr Virus Induced 3 |
|||
| 7-00263 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Epstein Barr Virus Induced 3 |
|||
| 7-00264 | CHI Scientific | 1mg | Ask for price |
Epstein-Barr Virus Induced 3 (EBI3) Antibody |
|||
| abx432634-200ul | Abbexa | 200 ul | EUR 286 |
Epstein-Barr Virus (HHV-4) p18 Protein |
|||
| 20-abx260115 | Abbexa |
|
|
Epstein-Barr Virus (HHV-4) p23 Protein |
|||
| 20-abx260116 | Abbexa |
|
|
Epstein-Barr Virus (HHV-4) EBNA1 Protein |
|||
| 20-abx260340 | Abbexa |
|
|
Epstein-Barr Virus (HHV-4) p18 Protein |
|||
| 20-abx260341 | Abbexa |
|
|
Epstein-Barr Virus Induced 3 (EBI3) Antibody |
|||
| abx232615-100ug | Abbexa | 100 ug | EUR 551 |
Epstein-Barr virus EBNA-1 Recombinant Protein |
|||
| 53-311 | ProSci | 0.01 mg | EUR 763.25 |
|
Description: Epstein-Barr virus EBNA-1 Recombinant Protein |
|||
AAV1-GFP Control Virus |
|||
| AAV-301 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 1. |
|||
AAV2-GFP Control Virus |
|||
| AAV-302 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 2. |
|||
AAV3-GFP Control Virus |
|||
| AAV-303 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 3. |
|||
AAV4-GFP Control Virus |
|||
| AAV-304 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 4. |
|||
AAV5-GFP Control Virus |
|||
| AAV-305 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 5. |
|||
AAV6-GFP Control Virus |
|||
| AAV-306 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: GFP control virus of AAV serotype 6. |
|||
AAV2-Cre Control Virus |
|||
| AAV-310 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 2. |
|||
AAV1-Cre Control Virus |
|||
| AAV-311 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 1. |
|||
AAV3-Cre Control Virus |
|||
| AAV-313 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 3. |
|||
AAV4-Cre Control Virus |
|||
| AAV-314 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 4. |
|||
AAV5-Cre Control Virus |
|||
| AAV-315 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 5. |
|||
AAV6-Cre Control Virus |
|||
| AAV-316 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Cre control virus of AAV serotype 6. |
|||
AAV2-Luc Control Virus |
|||
| AAV-320 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 2. |
|||
AAV1-Luc Control Virus |
|||
| AAV-321 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 1. |
|||
AAV3-Luc Control Virus |
|||
| AAV-323 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 3. |
|||
AAV4-Luc Control Virus |
|||
| AAV-324 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 4. |
|||
AAV5-Luc Control Virus |
|||
| AAV-325 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 5. |
|||
AAV6-Luc Control Virus |
|||
| AAV-326 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Luciferase control virus of AAV serotype 6. |
|||
scAAV1-GFP Control Virus |
|||
| AAV-331 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 1. |
|||
scAAV2-GFP Control Virus |
|||
| AAV-332 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 2. |
|||
scAAV3-GFP Control Virus |
|||
| AAV-333 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 3. |
|||
scAAV4-GFP Control Virus |
|||
| AAV-334 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 4. |
|||
scAAV5-GFP Control Virus |
|||
| AAV-335 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 5. |
|||
scAAV6-GFP Control Virus |
|||
| AAV-336 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: Self-complementary GFP control virus of AAV serotype 6. |
|||
AAV1-LacZ Control Virus |
|||
| AAV-341 | Cell Biolabs | 50 ?L | EUR 1018 |
|
Description: LacZ control virus of AAV serotype 1. |
|||
Inhibition of superior glycation end merchandise by isoferulic acid and its free radical scavenging functionality: An in vitro and molecular docking study.
Non-enzymatic glycation and Oxidation of some vital natural macromolecules are paramount inside the pathogenesis of various sicknesses along with diabetes and atherosclerosis.
- Hyperglycemia performs a key perform inside the pathological technique of diabetic issues by progressive accumulation of superior glycation end merchandise (AGEs) in physique tissues. Formation of AGEs on account of protein glycation is adopted by an elevated free radical train that furthermore contributes in course of the bio-macromolecular hurt.
- The present study aimed to guage the free radical scavenging and antiglycation functionality of isoferulic acid (IFA). The free radical scavenging train of IFA was measured using DPPH, FRAP, and metal chelating assays. IFA confirmed environment friendly reducing vitality, free radical scavenging train and metal chelation train in focus dependent technique.
- The antiglycation train of IFA was studied using quite a few spectroscopic strategies. The obtained outcomes had been validated with free amino, sulfhydryl group, carbonyl content material materials and AGEs formation. Secondary structural alterations had been monitored using spherical dichroism, morphology of aggregates was analyzed using transmission electron microscopy.
- Molecular docking reveals the doable binding location of IFA with inside the sub-domain IIA of human serum albumin (HSA).
LC/QTOF/MS/MS characterization, molecular docking and in silico toxicity prediction analysis on degradation products of anagliptin.
Pharmaceutical medicine are potential molecules with explicit natural train. Nonetheless, long-term use of these chemical molecules can impact the human physiological system because of their elevated ranges inside the human physique. Resulting from this truth, identification and development elucidation of impurities or degradation merchandise must be thought of in order to ensure drug safety.
The present study assessed the degradation behaviour of dipeptidyl peptidase-4 (DPP-4) inhibitor anagliptin under completely completely different stress conditions as per ICH suggestions Q1A (R2) adopted by elucidation of the development of degradation merchandise. All the stress samples had been analysed by using UPLC/PDA.
The superior separation of drug from its degradation merchandise was attained with time programmed gradient elution on BEH C18 (100 mm × 2.1 mm, 1.7 μm) column using 10 mM ammonium formate (aqueous) and acetonitrile (pure) as a result of the cell half components.
All the degradation merchandise of anagliptin had been characterised using LC/QTOF/MS/MS. In addition to, the train and toxicity of degradation merchandise had been determined by the use of molecular docking and in silico toxicity prediction analysis, respectively. The developed UPLC/PDA approach was validated as per ICH suggestions on the subject of specificity, accuracy, precision, linearity and robustnes
Molecular Distributions of Soluble Oxidation Merchandise from Coals Characterised by Mass Spectrometers.
Oxidation of three coals with rank from lignite to anthracite in NaOCl aqueous reply was investigated on this study. The oxidation merchandise had been characterised by using gasoline chromatography/mass spectrometry and direct analysis in real-time mass spectrometry.
The outcomes confirmed that almost all of pure compounds in coals had been reworked into water-soluble species under delicate conditions, even the anthracite. Benzene polycarboxylic acids (BPCAs) and chloro-substituted alkanoic acids (CSAAs) had been most important merchandise from the reactions.
The merchandise from lower rank coals embody considerable CSAAs and most merchandise from extreme rank coals are BPCAs. As coal rank will enhance, the yield of BPCAs with additional carboxylic groups will enhance.
Alpha-bungarotoxin CF488a |
|||
| 9-00005 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF568 |
|||
| 9-00006 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF568 |
|||
| 9-00006 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin |
|||
| 00010-1 | Biotium | 1MG | EUR 168 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Fluorescein-Alpha-bungarotoxin |
|||
| 00011 | Biotium | 500uG | EUR 367 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Tetramethylrhodamine-Alpha-bungarotoxin |
|||
| 00012 | Biotium | 500uG | EUR 383 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
| 00013 | Biotium | 10ST | EUR 417 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
| 00014 | Biotium | 10ST | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
| 00015 | Biotium | 500uG | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
| 00016 | Biotium | 10ST | EUR 523 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Biotin-xx-a-bungarotoxin |
|||
| 00017 | Biotium | 500uG | EUR 433 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Biotin-cAMP, diisopropylethylammonium salt: |
|||
| 00020 | Biotium | 1MG | EUR 314 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00020-1 | Biotium | 20ST | EUR 418 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Biotin-cGMP, diisopropylethylammonium salt: |
|||
| 00021 | Biotium | 1MG | EUR 344 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00021-1 | Biotium | 20ST | EUR 448 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Cyanine 644-cAMP: |
|||
| 00022 | Biotium | 1MG | EUR 491 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Cyanine 644-cAMP: (20x50ug) |
|||
| 00022-1 | Biotium | 20ST | EUR 625 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Fluorescein Methotrexate, triammonium salt: |
|||
| 00023 | Biotium | 1MG | EUR 281 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 139 |
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF543 |
|||
| 00026 | Biotium | 500uG | EUR 494 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Rhodamine phalloidin 300u |
|||
| 00027 | Biotium | 300 | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300 |
|||
Biotin-xx-phalloidin |
|||
| 00028 | Biotium | 100U | EUR 428 |
|
Description: Minimum order quantity: 1 unit of 100U |
|||
Fluorescein-phalloidin |
|||
| 00030 | Biotium | 300U | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Rhodamine 110 phalloidin |
|||
| 00032 | Biotium | 300ST | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300ST |
|||
Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
| 00033 | Biotium | 300EU | EUR 345 |
|
Description: Minimum order quantity: 1 unit of 300EU |
|||
Phalloidin, CF405M |
|||
| 00034 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF405M |
|||
| 00034-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
CF488A-cAMP |
|||
| 00036 | Biotium | 100ug | EUR 172 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
CF640R-cAMP |
|||
| 00037 | Biotium | 100ug | EUR 172 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Phalloidin, CF555 |
|||
| 00040 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF555 |
|||
| 00040-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF647 |
|||
| 00041 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF647 |
|||
| 00041-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF488A |
|||
| 00042 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF488A |
|||
| 00042-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF543 |
|||
| 00043 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF543 |
|||
| 00043-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF568 |
|||
| 00044 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF568 |
|||
| 00044-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF594 |
|||
| 00045 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF594 |
|||
| 00045-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF633 |
|||
| 00046 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF633 |
|||
| 00046-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660R |
|||
| 00047 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660R |
|||
| 00047-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680R |
|||
| 00048 | Biotium | 300U | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680R |
|||
| 00048-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF350 |
|||
| 00049 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF350 |
|||
| 00049-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF640R |
|||
| 00050 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF640R |
|||
| 00050-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF532 |
|||
| 00051 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF532 |
|||
| 00051-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660C |
|||
| 00052 | Biotium | 300U | EUR 442 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660C |
|||
| 00052-T | Biotium | 50U | EUR 133 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680 |
|||
| 00053 | Biotium | 300U | EUR 466 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680 |
|||
| 00053-T | Biotium | 50U | EUR 147 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF430 |
|||
| 00054 | Biotium | 300U | EUR 449 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF430 |
|||
| 00054-T | Biotium | 50U | EUR 139 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF440 |
|||
| 00055 | Biotium | 300U | EUR 449 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF440 |
|||
| 00055-T | Biotium | 50U | EUR 139 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Cholera Toxin Subunit B, CF488A conjugate |
|||
| 00070 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF568 conjugate |
|||
| 00071 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF594 conjugate |
|||
| 00072 | Biotium | 100ug | EUR 261 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF640R conjugate |
|||
| 00073 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF532 conjugate |
|||
| 00074 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF543 conjugate |
|||
| 00075 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF620R conjugate |
|||
| 00076 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF633 conjugate |
|||
| 00077 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF660R conjugate |
|||
| 00078 | Biotium | 100ug | EUR 264 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF680R conjugate |
|||
| 00079 | Biotium | 100ug | EUR 282 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Human Transferrin, CF488A conjugate |
|||
| 00081 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF543 conjugate |
|||
| 00082 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF568 conjugate |
|||
| 00083 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF594 conjugate |
|||
| 00084 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF640R conjugate |
|||
| 00085 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF680R conjugate |
|||
| 00086 | Biotium | 1mg | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF750 conjugate |
|||
| 00087 | Biotium | 1mg | EUR 155 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
HIV-1 tat recombinant antigen |
|||
| 00110-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: HIV-1 tat recombinant antigen full length 15 kDa |
|||
HIV-1 tat recombinant antigen |
|||
| 00110-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: HIV-1 tat recombinant antigen full length 15 kDa |
|||
HIV-1 GAG P24 Recombinant Antigen |
|||
| 00111-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
HIV-1 GAG P24 Recombinant Antigen |
|||
| 00111-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
HIV-1 nef recombinant antigen |
|||
| 00112-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
|||
HIV-1 nef recombinant antigen |
|||
| 00112-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
|||
HIV-1 env gp41 recombinant antigen |
|||
| 00113-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
|||
HIV-1 env gp41 recombinant antigen |
|||
| 00113-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
|||
HIV-2 GP 36 Recombinant Antigen |
|||
| 00114-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
|||
HIV-2 GP 36 Recombinant Antigen |
|||
| 00114-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
|||
HCV core recombinant antigen |
|||
| 00115-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
|||
HCV core recombinant antigen |
|||
| 00115-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
|||
HCV core recombinant antigen, Biotin conjugate |
|||
| 00115-V-B-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
|||
HCV core recombinant antigen, Biotin conjugate |
|||
| 00115-V-B-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
|||